title: Dyspepsia: is a trial of therapy appropriate?
abstract: Dyspepsia is a common, benign condition that may be distinguished from gastroesophageal reflux, irritable bowel syndrome and pancreatobiliary, coronary or musculoskeletal disease by a careful history and physical examination. However, the presence or absence of a peptic ulcer in dyspepsia can be determined only by an endoscopic examination or a barium-contrast radiograph. Although the American College of Physicians has recommended trying drug therapy for patients with dyspepsia before diagnostic tests are done, new data support early diagnosis. Although therapy is initially cheaper than endoscopic examination, over a year the costs even out because most patients with dyspepsia eventually need an endoscopic examination, and many patients with nonulcer dyspepsia are given medication unnecessarily. Endoscopic examination, if available to general practitioners, is the most cost-effective approach to dyspepsia. An approach that does not include endoscopy lacks the opportunity to offer patients convincing reassurance that their illness is not serious, which is arguably the most important treatment in cases of nonulcer dyspepsia. Studies supporting the use of endoscopic examination predate the treatment of peptic ulcers with antibiotics, which makes an initial endoscopic examination to determine whether the patient has an ulcer even more important.
authors.affiliation: University of Ottawa, Ont.
authors.forename: W G
authors.initials: WG
authors.lastname: Thompson
mesh_terms: D000897:Anti-Ulcer Agents / Q000191:economics*; D003362:Cost-Benefit Analysis; D004415:Dyspepsia / Q000188:drug therapy* / Q000191:economics / Q000209:etiology; D016099:Endoscopy, Gastrointestinal / Q000191:economics*; D006801:Humans; D010437:Peptic Ulcer / Q000150:complications / Q000175:diagnosis*
chemical_list: D000897:Anti-Ulcer Agents